Home Biosimilar Antibodies Others Others antibody Rovalpituzumab (Anti-DLL3) For research use only.
Not for use in humans.

Rovalpituzumab (Anti-DLL3)

Synonyms:

Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.

Rovalpituzumab (Anti-DLL3)

Purity & Quality Control

Batch: A252101 Purity: 99% Protein concentration: 8.52mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.

Product Details

CAS No. 1613313-01-1
Molecular Weight 150 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) supplier | purchase Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) cost | Rovalpituzumab (Anti-DLL3) manufacturer | order Rovalpituzumab (Anti-DLL3) | Rovalpituzumab (Anti-DLL3) distributor